Clinical Trial Update: Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SDX-101 (R-Etodolac) with chlorambucil and chlorambucil alone in chronic lymphocytic leukemia. The study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Chlorambucil (chlorambucil)
• SDX-101 (R-Etodolac) (R-Etodolac)

Snippet

Sponsor: Cephalon | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: TERMINATED